NetworkNewsBreaks

MondayFeb 24, 2020 1:50 pm

NetworkNewsBreaks – Millendo Therapeutics, Inc. (NASDAQ: MLND) Featured in ROTH Equity Research Report

Millendo Therapeutics (NASDAQ: MLND) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “Yesterday, MLND appointed a new CMO only ~2 months away from the Phase 2b ZEPHYR data. With $48.3M in cash and $123M market cap, investors have neglected this hidden gem story, which is likely to trade up 100-200% on positive top-line news. In this report, we summarize our thoughts on the new CMO and walk you through our data predictions.” To request access to the full report, visit http://nnw.fm/DXCr3 About Millendo Therapeutics, Inc. Millendo Therapeutics is a late-stage biopharmaceutical…

Continue Reading

MondayFeb 24, 2020 1:26 pm

NetworkNewsBreaks – Motorcar Parts of America, Inc. (NASDAQ: MPAA) Featured in ROTH Equity Research Report

Motorcar Parts of America (NASDAQ: MPAA) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “MPAA delivered a FQ3 miss and lowered FY'20 sales guidance. The quarter was impacted by mild weather that resulted in general industry softness and deferral of product orders. We believe the revenue miss represents as a temporary setback as MPAA remains on track to complete its expanded footprint by the end of FQ2'21, including two additional facilities in Mexico. We see the new manufacturing capability supporting sales growth and the expansion of margins. Maintain Buy, PT to…

Continue Reading

MondayFeb 24, 2020 1:07 pm

NetworkNewsBreaks – Atomera, Inc. (NASDAQ: ATOM) Featured in ROTH Equity Research Report

Atomera (NASDAQ: ATOM) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “ATOM will report 4Q19 earnings this week. We regard ATOM as a highly differentiated silicon enhancement IP vendor that is gaining traction with large semiconductor supply chain companies. We believe ATOM remains on-track for mid-2020 licensing ramp progress across a steadily broadening base of licensees. We believe ATOM remains well funded to execute on its initial customer ramp plans. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Atomera Incorporated Atomera Incorporated has developed…

Continue Reading

MondayFeb 24, 2020 12:45 pm

NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report

Xeris Pharmaceuticals (NASDAQ: XERS) was featured in a recent U.S. Equity Research Report published by Mizuho Securities USA LLC. The report reads, “We are including IQVIA scripts for Gvoke and glucagon below for the week ended 2/14/2020. Gvoke TRx was flat at 236 week over week; Gvoke NRx was +2.3% to 224 from 219 the prior week. Total Glucagon TRx was 12,531, +18.3% y/y; total Glucagon NRx was +20.8% y/y to 10,004.” To request access to the full report, visit http://nnw.fm/SaZ9d About Xeris Pharmaceuticals, Inc. Xeris (NASDAQ: XERS) is a specialty pharmaceutical company delivering innovative solutions to simplify the experience…

Continue Reading

MondayFeb 24, 2020 12:22 pm

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Featured in Mizuho Securities Research Report

Aerie Pharmaceuticals (NASDAQ: AERI) was featured in a recent U.S. Equity Research Report published by Mizuho Securities USA LLC. The report reads, “Aerie reported 4Q19 earnings after the close yesterday. Net product sales of $24.7 mil came in above FactSet consensus of $19.4 mil and Adj. EPS of $(0.96) was below FactSet consensus of $(0.79). We believe the company had a solid quarter and were particularly pleased by the company's strategic shift, which places an increased focus on net pricing per bottle. The company's 2020 revenue guidance of $100-110 mil looks achievable to us, and may be beatable. We believe…

Continue Reading

MondayFeb 24, 2020 11:59 am

NetworkNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) to Present at LD Micro Virtual Investor Conference on March 4

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that management will present at the LD Micro Virtual Investor Conference at 1:00 p.m. Eastern Time on March 4, 2020. According to the update, Sigma Labs Executive Chairman, Mark K. Ruport, will present an overview of the business model and growth initiatives. A presentation will accompany the webinar, which will be followed by a question and answer session. To access the webinar, visit http://nnw.fm/m824P To view the full press release, visit http://nnw.fm/K9ouK About Sigma Labs Sigma Labs, Inc. (NASDAQ: SGLB) is…

Continue Reading

MondayFeb 24, 2020 11:23 am

NetworkNewsBreaks – Nightfood Holdings Inc.’s (NGTF) Ice Cream Now Formally Recommended by APA for Pregnancy-Related Cravings

Nightfood Holdings (OTCQB: NGTF), the better-for-you ice cream company addressing America’s $50 billion-dollar nighttime snacking market, has announced that the American Pregnancy Association (“APA”) is now formally recommending Nightfood as the ice cream expectant women should turn to when experiencing pregnancy-related cravings. A national health organization committed to promoting reproductive and pregnancy wellness through education, support, advocacy and community awareness, the APA currently serves over five million women and families a month through their website and toll-free education helpline. “Over 130,000 visitors daily turn to the APA website for information about pregnancy health, nutrition, preparing for the birth experience, naming…

Continue Reading

MondayFeb 24, 2020 10:51 am

NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Underwriters Exercise of Overallotment Option

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced the exercise by the underwriters of the Company’s previously announced firm commitment underwritten offering which closed on February 18, 2020. According to the update, the exercise of the overallotment option and the underwriters purchase of 115,767 shares of common stock, each at the public offering price of $6.50, less the underwriters’ discount of $0.52 per share, resulted in net pricing of $5.98 per share. Trxade Group received approximately $0.7 million…

Continue Reading

MondayFeb 24, 2020 10:24 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Major CPG Company’s Results to Generate 6 to 1 ROAS and 4.5% Incremental Sales Lift Through Employment of BIGtoken

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announced the release of a new case study. According to the update, the study illustrates results when one of the largest global food and beverage companies activated BIGtoken to drive sales during the 2019 holiday season. The campaign featured opt-in panels and BIGtoken platform offers, whereby users answered questions about the brand and category, scanned receipts and shared other data points about their consumer journey. The high-value insights were then used to create audiences and messaging strategy pre-activation, as well as optimize against these insights throughout the…

Continue Reading

MondayFeb 24, 2020 9:48 am

NetworkNewsBreaks – Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces the Change of its Name to Bolt Metals Corp.

Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) today announced that it has changed its name to Bolt Metals Corp., with an effective date on or about February 26, 2020. The Company’s shares will continue to trade under the stock symbol "BOLT" on the Canadian Securities Exchange (“CSE”). Similarly, there will be no change to the Company’s trading symbol on the Frankfurt Exchange or the OTCQB. The Company is not subdividing, consolidating or otherwise altering its share capital in association with the name change, which does not affect the rights of and does not require further action by the…

Continue Reading